The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.72
Bid: 3.70
Ask: 4.08
Change: -0.19 (-4.86%)
Spread: 0.38 (10.27%)
Open: 4.00
High: 4.00
Low: 3.72
Prev. Close: 3.91
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement: Placing and Trading Update

18 Jul 2012 07:00

RNS Number : 8964H
Tanfield Group PLC
18 July 2012
 



The following amendment has been made to the 'Placing, Trading Update and Director's Dealing' announcement released on 17th July at 7am under RNS No: 7907H.

Roy Stanley's shares were originally listed as 12,478,756. The correct amount is 12,617,661.

All other details remain unchanged.

The full amended text is shown below.

 

For immediate release

18 July 2012

 

TANFIELD GROUP PLC ("Tanfield" or the "Company")

Tanfield Group plc placing raises £2m to support Smith Electric Vehicles Corp., trading update and Director's Dealing

Tanfield is pleased to announce that it has raised approximately £2.0m net of expenses to enable the company to provide a loan facility to its associate company Smith Electric Vehicles Corp. ("Smith"). These funds were raised by way of a placing of 5,135,714 new Ordinary Shares of 5 pence ("Shares") with institutional and other investors at a price of 42 pence per Share, realising gross proceeds of £2.2m.

Tanfield, which owns a 24% stake in Smith, has agreed to provide a short-term bridging loan to Smith, a US entity, to provide liquidity support prior to Smith's planned initial public offering ("IPO"). The loan matures 180 days from issuance and must be repaid upon the closing of Smith's IPO. Smith has engaged with its key shareholders to obtain bridge financing totalling in excess of $12m. Tanfield will earn market rates for the provision of the loan. In the event the IPO does not take place and the loan had been drawn down, Tanfield's loan, along with the other providers of bridging finance, would stand as a senior unsecured obligations of Smith.

Trading Update

In the first quarter of 2012, Tanfield raised approximately £11.4m net of expenses by way of a placing of new equity to invest in its supply chain. This enabled Tanfield to grow its global powered access business in response to its order book demand. Since that date, it has secured increased volumes from its suppliers, enabling increased output from all of its manufacturing sites. Demand for powered access products has held up and, as its lead times come down, order intake rates should continue to rise. Tanfield continues to expect to reach break-even volumes during the second half of the current financial year. Given the importance of managing working capital in its growth process, Tanfield chose to raise additional funds to support Smith rather than risk jeopardising the growth in its powered access business.

Darren Kell, Chief Executive, commented "Given that Tanfield is Smith's largest shareholder, Tanfield is keen to support the company in its planned IPO. This fundraising that will enable Tanfield to participate in a lending facility that gives Smith that support without risking the progress achieved year to date in the powered access business."

Directors Dealing

As a result of his participation in the placing Roy Stanley, a director of the Company, will acquire 238,905 Shares at a price of 42 pence each. Following this acquisition Mr. Stanley will hold 12,617,661 Shares.

Admission and Placing Statistics

Application has been made for the placing shares to be admitted to trading on AIM, which is expected to occur on the 23rd of July 2012.

The Placing Shares represent approximately 4.1 per cent. of the Company's existing Ordinary Shares and will, when issued, represent approximately 4.0 per cent. of the Company's share capital as enlarged by the placing.

Following Admission of the placing Shares, the Company will have 128,971,225 Ordinary Shares in issue. This figure may be used by Shareholders, from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

For further information:

 

 

Tanfield Group Plc

Darren Kell, Chief Executive

Charles Brooks, Finance Director

 

0845 155 7755

WH Ireland

James Joyce / Nick Field - Corporate Finance

Seb Wykeham / Ruari McGirr - Corporate Broking

 

020 7220 1666

Buchanan

Charles Ryland

Nicola Cronk

Catherine Breen

 

020 7466 5000

 

A registration statement relating to Smith's common stock has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGMNGNMGZZZ
Date   Source Headline
25th Apr 20249:14 amRNSReplacement Final Results for year end 31 Dec 2023
25th Apr 20247:00 amRNSFinal Results for the year ended 31 Dec 2023
20th Nov 20231:01 pmRNSSnorkel Investment Update
17th Aug 20237:00 amRNSSnorkel Investment Update
24th Jul 20237:00 amRNSInterim Results for the six-months to 30 June 2023
2nd Jun 20237:00 amRNSResult of AGM
18th May 20237:00 amRNSSnorkel Investment Update
21st Apr 20237:00 amRNSFinal Results and Notice of AGM
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSSnorkel Investment Update
15th Nov 20229:54 amRNSSnorkel Investment Update
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 202210:48 amRNSSnorkel Investment & Legal Proceeding Update
14th Oct 20221:17 pmRNSSnorkel Investment & Legal Proceeding Update
9th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
24th Aug 20227:00 amRNSSnorkel Investment & Loan Subscription Update
3rd Aug 20228:46 amRNSResult of AGM
19th Jul 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
26th May 202211:44 amRNSSnorkel Investment Update
24th May 20227:00 amRNSLoan Note Instrument
12th May 20224:40 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
10th May 20227:00 amRNSSnorkel Investment & Legal Proceedings Update
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 202212:56 pmRNSLoan Subscription Update
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
18th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSnorkel Legal Proceedings Update
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn
28th Jan 20224:36 pmRNSPrice Monitoring Extension
27th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:35 pmRNSPrice Monitoring Extension
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:35 pmRNSPrice Monitoring Extension
16th Dec 20214:42 pmRNSSecond Price Monitoring Extn
16th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20214:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
22nd Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSSnorkel Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.